Home

Joseph M Miller

CIK 1746372 · Chief Financial Officer · last filed 2026-03-03

Joseph M Miller is a Chief Financial Officer who has filed 28 SEC Form 4 insider transactions across 4 companies since 2018. The most recent filing, for AUPH, was dated May 11, 2026. Across all open-market trades the lifetime net is −$1.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.9M across reported positions. 18 SEC filings were submitted jointly with Cerecor Inc.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.87M

Companies

4

Total Filings

28

Lifetime Open-Market Net

-$1.35M

Filer Profile

Reported Address
C/O AURINIA PHARMACEUTICALS INC.
#140, 14315-118 AVENUE
EDMONTON T5L 4S6
Related Filers
Cerecor Inc. — 18 joint filings, latest 2022-04-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AUPH Chief Financial Officer 613,932 $16.08 $9.87M -$1.36M 10 2026-03-03
AVTX Director — $19.23 — $0 3 2022-04-04
Avalo Therapeutics, Inc. (CERC) Delisted Director 40,582 $2.93 $118.9K $10.8K 13 2021-07-02
Avalo Therapeutics, Inc. (CERCW) Delisted Chief Financial Officer 45,000 — — $0 1 2018-07-16

Recent Filings

28 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-05-11 AUPH Notice (144) −500,503 -$7.93M EDGAR
2026-03-03 AUPH Mixed +19,718 -$533.0K EDGAR
2026-02-23 AUPH Tax (F) −32,424 -$466.9K EDGAR
2026-01-05 AUPH Mixed +8,877 -$640.6K EDGAR
2025-03-04 AUPH Mixed +78,155 -$939.6K EDGAR
2024-03-07 AUPH Sell (S) −34,811 -$194.9K EDGAR
2024-02-22 AUPH Grant (A) +196,153 $0 EDGAR
2024-02-22 AUPH Sell (S) −11,398 -$100.1K EDGAR
2023-03-06 AUPH Mixed +218,125 -$101.0K EDGAR
2022-04-04 AVTX Grant (A) — $0 EDGAR
Showing 1–10 of 28
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.